Introduction
Tumor Necrosis Factor alpha (TNF) is a cytokine that acts as a key regulator of immune functions, and indeed it exerts pleiotropic effects in immunity, inflammation, control of cell proliferation, differentiation and apoptosis (1) (2) (3) . Other molecules share with TNF part of its effects and, not suprisingly, they are all evolutionarily related to TNF (4) . It is now recognized that TNF is the prototypical member of a growing family of cytokines (4) but, unlike the other members, TNF can trigger intracellular signals that lead either to cell survival and proliferation or death (1) (2) (3) (4) . This dual role is important as far as the regulation of immune response is concerned, since it acts as a molecular basis for cellular homeostasis. However, TNF is also a natural anti-tumor molecule and these opposing signals might lead to inhibition of tumor growth or, at the opposite, in the promotion of tumor development through direct (see e.g. ref. 5 ) and indirect mechanisms (e.g. by tissue remodelling and stromal development. See e.g. ref. 6 ).
Dissecting out the molecular mechanisms of TNF signaling is therefore crucial.
Several works have addressed the biochemical pathways of the TNF signaling cascade in a variety of cells and many molecular actors of this complex intracellular machinery have been discovered and studied (for a comprehensive review see ref. 7) . The astonishing complexity of the signal transduction machinery triggered by TNF has also attracted the attention of modelers who, using modern approaches common in systems biology, have attempted to unravel the switching mechanism between the pathways leading to cell survival or death through mathematical modeling and theoretical analysis (8) (9) (10) (11) (12) . These works have been focused on the interplay among intracellular molecules and on the network of reactions stimulated by binding of TNF on its type 1 receptor triggered by TNF binding to its receptor at the cell surface whereas the cell death pathway is triggered by internalized TNF/receptor complexes (13, 14) .
Here we focus on this important bifurcation between the two paths that occur early upon binding of TNF to TNF-R1, and develop a minimal model of TNF action that is suitable for inclusion in a numerical program that we are currently developing to study tumor spheroids (15, 16) . The actual feasibility of such a simulation program depends critically on a series of simplification steps, and in particular we proceed in a partly phenomenological way that leads to straightforward parameterizations. The present model follows the same basic principles and replaces some complex molecular pathways with simpler mechanisms, and yet it successfully captures the basic features of experimental toxicity data.
In the next sections, we briefly review current biological knowledge on TNF signaling in cells. Then we present the model and show how model outputs compare with actual data. Finally we explore the parameter space over a wide range of parameter values to investigate the structural stability and robustness of the numerical model.
Modeling TNF activity on cells

A short review of TNF biology
For the sake of clarity, we briefly review the basic facts on TNF. More detailed descriptions can be found in recent reviews such as (7).
TNF is a homotrimeric molecule that binds to two different receptors: TNF-R1 and TNF-R2 (7). TNF-R1 appears to be the key mediator of TNF signaling in both normal and tumor cells and for this reason we focus our analysis on this receptor. TNF-R1 has three subunits, and their cytoplasmic tails must be juxtaposd to trigger intracellular signaling. Two models of TNF-R1 subunits recruitment have been proposed over the years: the first assumes that the receptor subunits juxtapose upon binding of homotrimeric TNF which, therefore, would drive the assembly of active TNF-R1; the second, which is supported by recent experimental evidences, suggests that TNF-R1 subunits self-assemble in the absence of TNF thanks to a conserved extracellular domain called the Pre-Ligand Assembly Domain (PLAD, 17). In this case, signaling by pre-assembled receptors before TNF binding would be prevented by cytosolic negative regulators sych as the Silencer of Death Domain (SODD, 18).
Binding of TNF to TNF-R1 initiates a series of biochemical events in the cell that take place at the cytoplasmic tails of the receptor subunits and, in particular, at their specialized domains called Death Domains (DD). DD recruit the adaptor protein TRADD that acts as an assembly platform for at least two other proteins, RIP-1 and TRAF-2 (2, 3, 7) . This multiproteic complex initiates the signaling cascades resulting in NF-κB activation and hence gene activation and cell survival (2, 3, 7) . Among the genes that are expressed after NF-κB activation, there are those that code for the two proteins FLIP and IAP that inhibit the TNF apoptotic pathway (2, 3, 7) .
It has been recently demonstrated that the TNF apoptotic pathway is initiated by TNF/TNF-R1 complexes internalized into endocytic vesicles (14) . At this intracellular level, the multiproteic complexes associated to the receptors' tails modify and form the so-called Death Inducing Signaling Complex (DISC, 14), whereby TRADD recruits FADD and pro-caspase-8. This caspase then triggers the irreversible pathway leading to apoptosis and cell death. It has also been demonstrated that the fate of endosomes containing TNF/TNF-R1 complexes prior to their maturation into lysosomes is to fuse with vesicles from the trans-Golgi network (14) . They may contain two inactivated enzymes, pro-A-SMase and pre-pro-CTSD, whose activation is also triggered by the multiproteic complexes formed at the TNF-R1 cytoplasmic tails upon the formation of the multivesicle structure, and in particular by active caspase-8. Activation of ASMase/CTSD cascade is also capable of mediating apoptosis via Bid cleavage and caspase-9 activation (14) .
Both the NF-κB and the apoptotic pathways comprise a series of complex intracellular reactions involving a number of enzymes and substrates (2, 3, 7) . These have been the subject of intense modeling efforts aimed at explaining the response of individual cells to TNF from a systemic perspective at the molecular level (8) (9) (10) (11) (12) . To the best of our knowledge these models do not focus on the different timing of the two pathways, but rather on the switching dynamics of the underlying biochemical system, resulting from feedback motifs detected at subcellular level. Indeed, current biological data indicate that activation of NF-κB and caspases occurs at different sites in the cells (at the cell membrane and upon internalization in endosome, respectively), at different times.
Binding and internalization of TNF/TFN-R1 complexes
Current biochemical data show that the TNF-R1 receptors rapidly self-trimerize at the cell membrane because of the PLAD domains and interact with TNF homotrimers (17) .
Thus, the mechanism of TNF binding to TNF-R1 can in principle be viewed as the result of the monomeric interactions between one molecule of TNF and one molecule of receptor. This semplification is futher supported by the following considerations:
1. the mechanism of receptor self-trimerization followed by ligand binding can be ligand/receptor complexes could be recycled back at the cell surface (19) . Recent data, however, show that the final fate of the endosomes containing TNF complexes is to maturate to lysosomes by progressive fusion with vesicles from the trans-Golgi network loaded with lysosomal enzymes (see also the previous section and ref. 14) , and thus it is highly probable that TNF/TNF-R1 complexes do not recycle at all but are finally degraded into lysosomes. Therefore we modify the model by Bajzer et al. as follows (see also Fig.1 ):
where square brackets denote molar concentrations of free TNF-R1 receptors (R), free TNF (L), TNF/TNF-R1 complexes bound at the cell membrane (Nc) and internalized complexes (Nin). Here k on and k off are the association and dissociation rate constants for TNF binding to TNF-R1, respectively, k in is the internalization rate constant of TNF/TNF-R1 complexes and k deg is the rate constant of lysosomal degradation of the complexes.
The two parameters V r and k d where introduced by Bajzer et al. (19) , although with a slightly different notation, to describe "the zero-order rate of insertion of receptors into the membrane and the turnover (internalization) rate constant of ligand-free receptors" (19, 20) respectively. This is an important aspect of the model since, in the absence of TNF, it reaches a steady concentration of receptors at the cell surface given by:
In addition, for long times these terms prevent receptor loss (i.e. downmodulation) from the cell surface, a process that would undesirably result in cell resistance to TNF independently of the dynamic interplay between the intracellular paths triggered by TNF. Here we model both biochemical circuits by means of only two molecular species, that we denote with B and A, that collectively summarize the various reactions leading to cell survival and death, respectively, and the interplay between the two paths. The, molecules B and A can be loosely identified with NF-κB/FLIP and caspase-8, respectively (Fig.1) . We assume that after the initial trigger both pathways proceed irreversibly to their endpoint. In this way we neglect many details of both pathways which involve a number of different molecular actors, and thus we neglect all those reactions that probabily serve to fine tune the effects of TNF. Finally, we introduce a population variable f (t) , the fraction of surviving cells at time t . The equations for A and B are:
Modeling the intracellular signaling pathways triggered by TNF
where the variables Nc and Nin are the same as in the differential system [1] .
We see from the differential system [3] , that the cell survival signal, modeled 
Mathematical methods
Eventually, the systems of equations [1] 
Results
Binding and internalization kinetics
We have estimated the parameters related to TNF binding and internalization by fitting equations [1] [ ](t) was fitted to experimental data of total cell-associated radioactivity. Fig.1 shows the data in (21) along with the best fit to the data using the set of differential equations [1] .
Although the data set contains only 9 data points and the model has 6 parameters, the fit can still be performed, (we find χ 2 = 9.0 , which corresponds to a 3% statistical significance) , and the estimated parameter values are as follows: Presently we do not aim at precise parameter estimates for a specific cell line, but rather at a general test of the validity of the model; we also seek to determine its robustness with respect to parameter changes (see also the Discussion section).
Therefore we used equations [1] with the parameter values given above to model TNF binding and internalization and then attempted to fit cytotoxicity data in (29) using equations [3] . The initial conditions that are needed to solve the differential system were taken from the experiments by Scherf et al. (29) , that were carried out by plating a different number of cells in a higher volume of growth medium rather than those by
Grell et al. (21) . The results are shown in Fig.3 .
The estimated parameter values are as follows:
To test the stability of the outputs in Fig.3 we simulated the cytotoxic effects for MCF7 cells at different TNF doses administered for increasing times. The results in Fig.4 show that the simulated cytotoxic effects saturates after approximately 44 hours, and that no further TNF-mediated cytotoxicity can be observed after that time. It is worth noting that the maximal observed cytotoxic effect in Fig.4 corresponds to a surviving fraction f = 0.038 . That is to say, 3.8 % of the cells survive independently of TNF concentration and treatment time.
Exploring the space of parameters
Our model of TNF cytotoxicity is collectively given by equations [1] , describing uptake and internalization of TNF, and equations [3] , describing intracellular processes f (t) = f (∞) ), and this was calculated after 20.000 min (approx. 14 days) of TNF treatment to allow any transient to settle down. In Fig.6 we also change the values of two parameters at the same time. In this case TNF concentration was set to 1.7 ⋅10 −11 M , which is the IC50 for MCF7 cells (IC50 = concentration that inhibit 50% cell survival, see Fig.3 ).
Results in both Fig.5 and Fig.6 show that no unexpected and/or undesired patterns emerge, and that the model actually describes a balance between cell survival and death for a broad range of parameter values. Thus the model is structurally stable and robust with respect to parameter variations.
Discussion
We have developed a minimal quantitative model of TNF cytotoxicity. The model is minimal because it takes into consideration only those reactions that, in our opinion, are essential to describe the action of TNF on cell survival and death.
We have modeled TNF binding and its uptake by cells, and it is worth noting that the estimated parameter values are biologically relevant. In fact:
1. the ratio V r k d (equation [2] ) determines the concentration of TNF receptors in the cell population at equilibrium. Substituting the estimated values, we obtain Because of its favorable properties, our model is suitable for integration into complex multi-scale simulation programs of tumor growth such as VBL (15, 16) . We plan to use equations [1] and [3] . Parameters in equations [1] assume the values estimated by fitting of binding kinetics data as shown in Fig.2 . Experimental error was not given in the original data. These can be compared to the reference bar given on top. was computed for a fixed concentration of TNF that was set at the IC50 value measured for MCF7 cells (see Fig.3 ). 
